Speranza Therapeutics
Early Stage
Bridging the gap between hope and healing
Overview
Raised: $6,624
Total Commitments ($USD)
Platform
StartEngine
Start Date
03/13/2022
Close Date
08/01/2022
Min. Goal
$9,997
Max. Goal
$1,069,996
Min. Investment
$599
Security Type
Equity - Common
Series
Seed
SEC Filing Type
RegCF
Price Per Share
$6.89
Pre-Money Valuation
$7,666,882
Rolling Commitments ($USD)
Status
Not Funded
Reporting Date
08/30/2022
Days Remaining
Not Funded
% of Min. Goal
Not Funded
% of Max. Goal
Not Funded
Likelihood of Max
Not Funded
Avg. Daily Raise
$47
# of Investors
11
Momentum
Not Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2019
Industry
Healthcare & Pharmaceuticals
Tech Sector
Biotech
Distribution Model
B2B
Margin
Medium
Capital Intensity
High
Speranza Therapeutics, with a valuation of $7.67 million, is raising funds on StartEngine. It is a medical device and biotechnology company that makes and distributes medical devices and generic drugs to treat a variety of diseases. The company is developing S.T. Genesis, a medical device to help reduce opioid uses withdrawal symptoms, and Soothe-OM, a mucoadhesive product to treat oral mucocitis. Sal Rafanelli founded Speranza Therapeutics in September 2019. The current crowdfunding campaign has a minimum target of $9,997.39 and a maximum target of $1,069,996.33. The campaign proceeds will be used for clinical trials, receiving approvals, and launching the products.
Summary Profit and Loss Statement
| Most Recent Year | Prior Year | |
|---|---|---|
|
Revenue |
$0 |
$789,775 |
|
COGS |
$0 |
$518,475 |
|
Tax |
$0 |
$12,177 |
| ||
| ||
|
Net Income |
$0 |
$-1,594,376 |
Summary Balance Sheet
| Most Recent Year | Prior Year | |
|---|---|---|
|
Cash |
$0 |
$32,002 |
|
Accounts Receivable |
$0 |
$129,134 |
|
Total Assets |
$0 |
$1,532,092 |
|
Short-Term Debt |
$0 |
$869,977 |
|
Long-Term Debt |
$0 |
$0 |
|
Total Liabilities |
$0 |
$869,977 |
Financials as of: 03/13/2022
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Already a member? Log in here.
Ratings 
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.